Monster Beverage at 41 Times Earnings, No Dividend Cushion
Monster Beverage trades around $44.71 as I write this, 41.4 times trailing earnings, for a company that pays no dividend. That is a rich price, and this year it got harder to argue with.
Revenue in the June quarter rose 20% year over year to $2.5 billion, the latest step in a real turnaround. A year earlier, growth had slowed to under 5%.
At an $87.6 billion market cap, Monster ranks among the larger pure-play beverage names, small next to Coca-Cola or PepsiCo but large enough that a single disappointing quarter moves real money rather than getting lost in a bigger portfolio.
Monster’s growth has caught up with its multiple, but the price now asks investors to believe the acceleration holds for years rather than quarters, and that is a harder case to make than the recent numbers alone suggest.
Growth caught up with the price
Go back three years and the pattern is uneven. Revenue grew 13.9% in 2022 and another 13.1% in 2023, then slowed sharply to 4.9% in 2024 as demand normalized and prior price increases lapped themselves. It reaccelerated to 11% for full-year 2025, reaching $8.3 billion, and the quarterly pace since has run hotter still, finishing at 20% in the latest quarter with 8% sequential growth over the prior quarter. That is not just an easy comparison against a weak prior year; it is the second straight quarter above 15%.
It is the same premium-multiple test I have run on Costco, TJX, Walmart, Five Below and Ulta: the market keeps paying up for consistency until the quarter that breaks the pattern arrives.
Profit followed, though not in a straight line. Net income rose to $1.9 billion, a net margin of 23%. Operating margin reached 29%, and gross margin improved to 55.8% from 54.0% a year earlier, evidence that pricing and mix are doing real work, not just volume.
Operating income itself has not moved in a straight line the way the headline growth numbers suggest. It fell 11.8% in 2022 as aluminum and freight costs spiked, rebounded 23.3% in 2023 as those costs eased, slipped 1.2% in 2024, then jumped 25.3% in 2025 to $2.4 billion. Some of the current margin gain is cost relief; some of it is pricing that has held even as volumes grew. Both can reverse if input costs turn again, which is worth remembering before extrapolating the last two quarters in a straight line.
Here is the catch. Forward earnings imply growth of about 14%, well under the 20% the top line just posted. If that gap holds, profit keeps arriving slower than sales, and at a 41.4 multiple the market has less patience for that kind of lag than it did a year ago.
What 41 times earnings assumes
The trailing multiple of 41.4 sits above Monster’s own five-year average of 38.6, and well above the roughly 24 average for packaged food and beverage peers. Forward P/E is lower, at 36.3, priced off $1.23 in expected earnings versus $1.08 trailing. Price to sales tells a similar story: 9.5 now against a five-year average of 8.4.
I asked almost the same question about Cintas trading at 40 times earnings earlier this year: growth can justify a premium multiple only as long as it keeps compounding faster than the price already assumes it will.
None of this is unreasonable for a company growing revenue at 20%. It is unreasonable for a company that might grow revenue at 5%, which is exactly what happened two years ago. The multiple is a bet that 2024 was the anomaly and this year is the real trend line.
There is a demand argument for paying up. The global energy-drink category runs around $100 billion in retail sales and has grown at a mid-single-digit pace in the US over the past decade, faster than the low-single-digit growth of soft drinks generally. Monster is not fighting a shrinking pool; it is fighting for share of one that keeps expanding, even if slowly. That is a better setup than a mature category in decline, and it is the reason the multiple has not collapsed even in years when growth slowed.
Capital allocation is part of the story too. Monster returns cash to shareholders through buybacks rather than a dividend, and its balance-sheet multiple reflects the same optimism as its earnings multiple: price to book of 9.4 against a five-year average of 8.1. Paying nearly ten times book value for a beverage company only works if returns on that capital stay well above the cost of it.
| Metric | Value | Comparison |
|---|---|---|
| Price | $44.71 | 10.9% below the 52-week high of $50 |
| Trailing P/E | 41.4x | 5-year average 38.6x; beverage peers around 24x |
| Forward P/E | 36.3x | on $1.23 forward EPS vs $1.08 trailing |
| Price/sales | 9.5x | 5-year average 8.4x |
| FY2025 revenue | $8.3 billion | up 11% from $7.5 billion in FY2024 |
| Latest quarter revenue | $2.5 billion | up 20% year over year |
| Net margin | 23% | operating margin 29% |
| Average analyst target | $52 | 17% above the current price |
One category, one distribution partner
Energy drinks are effectively the whole business; strategic brands and the newer alcohol lineup are a small fraction of sales and have not changed that. The category has been kind to Monster. Its Coca-Cola distribution deal, in place since 2015 on an initial 20-year term running through 2035, gives the brand a bottling and logistics network far bigger than anything it could build alone, and Coke gets exposure to a faster-growing category without running a competing energy brand of its own after an earlier in-house attempt was shelved within 18 months.
That access shows up in volume share. Monster holds roughly 17% of the global energy-drink category by volume, ahead of Red Bull’s 13%, and in North America, where Monster generates over half its sales, its share is closer to 43% against Red Bull’s 24%. It spends to defend that gap: about $600 million on advertising and marketing in 2025, roughly 7% of sales, smaller in dollar terms than Coca-Cola’s $5.4 billion or PepsiCo’s $5.4 billion but a bigger share of its own revenue base.
Where Monster has diversified is inside the category, not outside it. Monster Super Fuel targets the workout crowd with added electrolytes, Juice Monster leans into fruit flavors for a lighter drinker, Monster Rehab is a non-carbonated tea-based line, and Java Monster is coffee and dairy based. Each extension still sells through the same Coke trucks under the same Monster claw logo; none of it reduces the single-category bet the way a separate business line would.
The concentration cuts both ways. A single hot category funded by a single bottler is efficient until it is not. Regulatory scrutiny of caffeine content and marketing to younger consumers has been building in Europe and surfaces periodically in US state legislatures. Nothing has passed that materially restricts Monster’s US business yet. That is the kind of risk that does not show up in a valuation model until it does.
Where the sell side disagrees
Fifteen analysts cover the stock, and 73% rate it a buy with the rest at hold, none at sell. The average target is $52, 17% above the current price, in a range that runs from $48 to $56.
That range undersells how split the individual calls are. Morgan Stanley has kept a buy rating with a $55 target through September. RBC Capital’s model, reiterated in early August, implies a target near $97, more than double the current price, a real outlier even among the bulls. J.P. Morgan sits at hold with a $49.50 target, barely above where the stock trades now. For tracking a spread like that across a dozen firms, a workflow closer to the one I described using Seeking Alpha to raise a win rate beats checking one target at a time.
When the holders cluster near the current price and the buyers diverge this much, the disagreement is not really about the business. It is about how many more years of 20% growth to pay for today.
The stock’s average earnings-day move runs about 6.1%, and it fell roughly -4.0% on its last report on 2026-08-06. That is not a stock the market treats as settled.
Sentiment tools tell a quieter story than the price targets do. The site’s own quant score, a blend of momentum, valuation and estimate-revision factors, has held steady at a C rating through most of September, neither improving nor deteriorating around the last earnings reaction. Short interest is a similarly unremarkable 2.2% of the float. Read together, that tells me the disagreement here is about valuation discipline, not about traders positioning for a specific near-term catalyst.
Where this view could break
The clearest uncertainty here is duration. If Monster grows revenue in the high teens for another two or three years and profit catches up, a 41 multiple will look reasonable in hindsight. I would be wrong to call this stock overpriced if that plays out, and I want to be honest that growth already reaccelerated once, from under 5% to over 20% in five quarters, so betting on a second deceleration this soon is a contrarian call for its own sake.
My real uncertainty is whether I am underweighting how sticky the current pricing and mix gains are. A gross-margin gain of nearly two points in a year is not something that typically reverses on its own.
Where I would actually get nervous is a regulatory move on caffeine limits or marketing rules that slows volume growth back toward mid-single digits. At a peer multiple near 24, not 41, this stock would trade closer to $27 on today’s earnings, which is the kind of gap that makes concentration risk worth respecting even while the current numbers are working.
The number that would change my mind
I would not chase Monster Beverage at 41.4 times earnings today. I would want two more quarters of revenue growth above 15% with earnings growth closing the gap toward it, not just matching a low bar set by a weak 2024. If growth drops back under 10% before that happens, the multiple has further to fall than the current 10.9% pullback from the 52-week high suggests.
Analysis and opinion only, not investment advice. Figures come from Monster Beverage’s quarterly filings on SEC EDGAR and its investor site; valuation multiples and analyst estimates are approximate and were checked on September 18, 2026.
Sources: Dividends (SEC Investor.gov glossary) (https://www.investor.gov/introduction-investing/investing-basics/glossary/dividend) · Dividends tax topic (IRS) (https://www.irs.gov/taxtopics/tc404)